Artificial Intelligence (AI) in Precision Medicine Market (By Technology: Machine Learning, Querying Method, Deep Learning, Context-Aware Processing, Natural Language Processing; B: Hardware, Software, Service; By Therapeutic Application: Oncology, Neurology, Cardiology, Respiratory, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence (AI) in Precision Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence (AI) in Precision Medicine Market, by Technology, 2023-2032
8.1.1 Machine Learning
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Querying Method
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Deep Learning
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Deep Learning
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Context-Aware Processing
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Natural Language Processing
8.1.6.1. Market Revenue and Forecast (2020-2032)
9.1. Artificial Intelligence (AI) in Precision Medicine Market, by Component, 2023-2032
9.1.1. Hardware
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Software
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Service
9.1.3.1. Market Revenue and Forecast (2020-2032)
10.1. Artificial Intelligence (AI) in Precision Medicine Market, by Therapeutic Application, 2023-2032
10.1.1. Oncology
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Neurology
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Cardiology
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Respiratory
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
11.1. North America
11.1.1. Market Revenue and Forecast, by Technology (2020-2032)
11.1.2. Market Revenue and Forecast, by Component (2020-2032)
11.1.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Technology (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Component (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Technology (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Component (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Technology (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Component (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.5.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Technology (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Component (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Technology (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Component (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Therapeutic Application (2020-2032)
12.1. Novo Nordisk A/S
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GE Healthcare
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Intel Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. NVIDIA Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Microsoft Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Alphabet Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. IBM Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. BioXcel Therapeutics Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Enlitic Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. AstraZeneca
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample